sodium phenylacetate
Recently Published Documents


TOTAL DOCUMENTS

41
(FIVE YEARS 7)

H-INDEX

11
(FIVE YEARS 0)

2017 ◽  
Vol 2017 ◽  
pp. 1-4 ◽  
Author(s):  
Melis Köse ◽  
Ebru Canda ◽  
Mehtap Kagnici ◽  
Sema Kalkan Uçar ◽  
Mahmut Çoker

In treatment of metabolic imbalances caused by maple syrup urine disease (MSUD), peritoneal dialysis, and hemofiltration, pharmacological treatments for elimination of toxic metabolites can be used in addition to basic dietary modifications. Therapy with sodium phenylacetate/benzoate or sodium phenylbutyrate (NaPB) in urea-cycle disorder cases has been associated with a reduction in branched-chain amino acid (BCAA) concentrations when the patients are on adequate dietary protein intake. Moreover, NaPB in treatment of MSUD patients is also associated with reduction of BCAA levels in a limited number of cases. However, there are not enough studies in the literature about application and efficacy of this treatment. Our case report sets an example of an alternative treatment’s efficacy when extracorporeal procedures are not available due to technical difficulties during attack period of the disease.


Sign in / Sign up

Export Citation Format

Share Document